Journal article
Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia
B Panizzutti, CC Bortolasci, B Spolding, S Kidnapillai, T Connor, MF Richardson, TTT Truong, ZSJ Liu, G Morris, L Gray, JH Kim, OM Dean, M Berk, K Walder
International Journal of Molecular Sciences | Published : 2021
DOI: 10.3390/ijms22137164
Abstract
Recent reports suggest a link between positive regulation of the Hippo pathway with bipolar disorder (BD), and the Hippo pathway is known to interact with multiple other signaling pathways previously associated with BD and other psychiatric disorders. In this study, neuronal-like NT2 cells were treated with amisulpride (10 µM), aripiprazole (0.1 µM), clozapine (10 µM), lamotrigine (50 µM), lithium (2.5 mM), quetiapine (50 µM), risperidone (0.1 µM), valproate (0.5 mM), or vehicle control for 24 h. Genome-wide mRNA expression was quantified and analyzed using gene set enrichment analysis (GSEA), with genes belonging to Hippo, Wnt, Notch, TGF-β, and Hedgehog retrieved from the KEGG database. Fi..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This research was funded by National Health & Medical Research Council (NHMRC), Project Grant (GNT1078928).